Company
United StatesPublic company, NASDAQ: KURAKURA ONCOLOGY INC (NASDAQ: KURA), San Diego, CA – FDA Inspections
Inspection records and compliance data for KURA ONCOLOGY INC in San Diego, California. 1 FDA inspection on record, last inspected June 27, 2025. Publicly traded as NASDAQ: KURA.
Company Profile
This profile covers KURA ONCOLOGY INC based in San Diego, California, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected June 27, 2025.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 27, 2025 | NAI | Human Drugs · Bioresearch Monitoring | 1276133 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
KURA ONCOLOGY INC
Stock ticker
KURA
Exchange
NASDAQ
Share price
$6.82
Market cap
$606.3M
Price as of
November 6, 2026
FEI Number
3017920772
Address
12730 High Bluff Dr Ste 400, San Diego, California 92130, United States
Country
United States
ID: 38bd7c96-e0ca-4c03-b900-fd824e5c12f8